Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -13.09% is 31% above its 5-year average of -18.86%, around the middle of its 5-year range (-31.12%–-1.74%).
As of the fiscal period ended Tuesday, June 30, 2026. 48.71% below its 12-month average of -8.80%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -13.09%.
RETURN ON EQUITY (ROE)
-13.09%
RETURN ON EQUITY (ROE) AVG TTM
-8.80%
RETURN ON EQUITY (ROE) AVG 3Y
-14.27%
RETURN ON EQUITY (ROE) AVG 5Y
-18.86%
RETURN ON EQUITY (ROE) AVG 10Y
-19.48%
RETURN ON EQUITY (ROE) AVG 15Y
-40.57%
RETURN ON EQUITY (ROE) AVG 20Y
-57.19%
CURRENT VS TTM AVG
-48.71%
CURRENT VS 3Y AVG
+8.27%
CURRENT VS 5Y AVG
+30.59%
CURRENT VS 10Y AVG
+32.78%
CURRENT VS 15Y AVG
+67.73%
CURRENT VS 20Y AVG
+77.11%
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 623 covered companies
CURRENT VS SECTOR MEDIAN
+67.43%
vs the sector median at left
AxoGen, Inc.
Market Cap
$1.96B
Return on Equity (ROE)
-13.09%
TTM Avg
-8.80%
3Y Avg
-14.27%
5Y Avg
-18.86%
Market Cap
$1.95B
Return on Equity (ROE)
-48.43%
TTM Avg
-97.59%
3Y Avg
-126.46%
5Y Avg
-100.04%
Market Cap
$1.93B
Return on Equity (ROE)
-179.99%
TTM Avg
-188.10%
3Y Avg
28.98%
5Y Avg
-2.67%
Market Cap
$2.01B
Return on Equity (ROE)
16.36%
TTM Avg
13.19%
3Y Avg
3.41%
5Y Avg
-4.94%
Market Cap
$2.01B
Return on Equity (ROE)
-63.45%
TTM Avg
-58.44%
3Y Avg
-22.42%
5Y Avg
15.04%
Market Cap
$2.03B
Return on Equity (ROE)
51.09%
TTM Avg
25.46%
3Y Avg
0.90%
5Y Avg
-9.89%
Market Cap
$1.89B
Return on Equity (ROE)
-40.09%
TTM Avg
4.56%
3Y Avg
-13.84%
5Y Avg
-2.18%
Market Cap
$2.04B
Return on Equity (ROE)
17.35%
TTM Avg
12.11%
3Y Avg
10.87%
5Y Avg
16.24%
Market Cap
$1.89B
Return on Equity (ROE)
12.01%
TTM Avg
-4.52%
3Y Avg
-16.89%
5Y Avg
-11.36%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AxoGen, Inc. (AXGN) | $1.96B | -13.09% | -8.80% | -14.27% | -18.86% |
| Immunome, Inc. (IMNM)vs › | $1.95B | -48.43% | -97.59% | -126.46% | -100.04% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.93B | -179.99% | -188.10% | 28.98% | -2.67% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.01B | 16.36% | 13.19% | 3.41% | -4.94% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.01B | -63.45% | -58.44% | -22.42% | 15.04% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.03B | 51.09% | 25.46% | 0.90% | -9.89% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | -40.09% | 4.56% | -13.84% | -2.18% |
| Progyny, Inc. (PGNY)vs › | $2.04B | 17.35% | 12.11% | 10.87% | 16.24% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 12.01% | -4.52% | -16.89% | -11.36% |
| Azenta, Inc. (AZTA)vs › | $1.86B | -8.14% | -6.28% | -6.47% | -2.03% |
ROE
-13.1%
ROA
-11.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -13.09% |
| 2026-03-31 | -12.85% |
| 2025-12-31 | -12.19% |
| 2025-09-30 | -1.74% |
| 2025-06-30 | -4.15% |
| 2025-03-31 | -6.80% |
| 2024-12-31 | -9.59% |
| 2024-09-30 | -14.39% |
| 2024-06-30 | -17.28% |
| 2024-03-31 | -22.84% |
| 2023-12-31 | -22.70% |
| 2023-09-30 | -23.76% |
| 2023-06-30 | -24.15% |
| 2023-03-31 | -25.17% |
| 2022-12-31 | -28.66% |
| 2022-09-30 | -28.41% |
| 2022-06-30 | -31.12% |
| 2022-03-31 | -30.62% |
| 2021-12-31 | -23.98% |
| 2021-09-30 | -24.04% |
| 2021-06-30 | -18.57% |
| 2021-03-31 | -18.59% |
| 2020-12-31 | -19.31% |
| 2020-09-30 | -20.39% |
| 2020-06-30 | -24.14% |
| 2020-03-31 | -22.40% |
| 2019-12-31 | -22.05% |
| 2019-09-30 | -20.18% |
| 2019-06-30 | -18.74% |
| 2019-03-31 | -18.66% |
| 2018-12-31 | -15.24% |
| 2018-09-30 | -13.16% |
| 2018-06-30 | -11.75% |
| 2018-03-31 | -56.81% |
| 2017-12-31 | -41.48% |
| 2017-09-30 | -128.63% |
| 2017-06-30 | -121.62% |
| 2017-03-31 | -119.57% |
| 2016-12-31 | -96.58% |
| 2016-06-30 | -467.90% |
| 2016-03-31 | -278.09% |
| 2015-12-31 | -162.97% |
| 2015-09-30 | -145.28% |
| 2013-09-30 | -352.21% |
| 2012-09-30 | -623.49% |
| 2012-06-30 | -256.49% |
| 2012-03-31 | -219.34% |
| 2011-12-31 | -151.84% |
| 2011-09-30 | -93.70% |
| 2011-06-30 | -45.78% |
| 2011-03-31 | -34.47% |
| 2010-12-31 | -17.89% |
| 2010-09-30 | 134.00% |
| 2010-06-30 | 136.77% |
| 2010-03-31 | 137.60% |
| 2009-12-31 | 136.03% |
| 2009-09-30 | -132.51% |
| 2009-06-30 | -220.10% |
| 2009-03-31 | -568.08% |
| 2008-12-31 | -332.34% |
| 2008-09-30 | -216.46% |
| 2008-06-30 | -144.83% |
| 2008-03-31 | -107.50% |
| 2007-12-31 | -83.28% |
| 2007-09-30 | -95.49% |
| 2007-06-30 | -46.63% |
| 2007-03-31 | -36.31% |
| 2006-12-31 | -28.34% |
| 2006-09-30 | -5.53% |
| 2006-06-30 | -1.17% |
| 2006-03-31 | 0.38% |
| 2005-12-31 | -31.87% |
| 2005-09-30 | 24.41% |
| 2005-06-30 | 95.55% |
| 2005-03-31 | 94.39% |
| 2004-12-31 | 100.02% |
| 2004-09-30 | 89.71% |
| 2003-06-30 | -548.88% |
